4//SEC Filing
Gibbs Michael Terrence 4
Accession 0000950170-24-017073
CIK 0001492674other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:00 PM ET
Size
6.7 KB
Accession
0000950170-24-017073
Insider Transaction Report
Form 4
Gibbs Michael Terrence
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-02-20+40→ 106 total - Exercise/Conversion
Restricted Stock Units
2024-02-20−40→ 40 total→ Common Stock (40 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On February 20, 2022 the reporting person was granted 120 RSU's that vest annually in three substantially equal installments commencing on February 20, 2023.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001665000
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:00 PM ET
- Size
- 6.7 KB